Robert A. Essner's most recent trade in Organon & Co. was a trade of 9,638 Phantom Stock done . Disclosure was reported to the exchange on June 7, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Organon & Co. | Robert A. Essner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 9,638 | 36,454 | - | - | Phantom Stock | |
| Organon & Co. | Robert A. Essner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 10,086 | 25,285 | - | - | Phantom Stock | |
| Organon & Co. | Robert A. Essner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 5,640 | 14,638 | - | - | Phantom Stock | |
| Amicus Therapeutics Inc | Robert A. Essner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 36,111 | 36,111 | - | - | Stock Options (right to buy) | |
| Amicus Therapeutics Inc | Robert A. Essner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,115 | 31,115 (0%) | 0% | 0 | Common Stock | |
| Organon & Co. | Robert A. Essner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 8,772 | 8,772 | - | - | Phantom Stock |